tibolone has been researched along with Hot Flashes in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (4.17) | 18.2507 |
2000's | 32 (66.67) | 29.6817 |
2010's | 14 (29.17) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abad, P; Baró, F; Cancelo, MJ; Llaneza, P; Manubens, M; Mendoza, N; Quereda, F; Sánchez-Borrego, R | 1 |
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E; Wilkinson, J | 1 |
Beckmann, MW; Bundred, NJ; Egberts, J; Foidart, JM; Kenemans, P; Kubista, E; Mol-Arts, M; Mulder, R; Sismondi, P; van Os, S; Vassilopoulou-Sellin, R; von Schoultz, B; Yip, CH | 1 |
Goodwin, PJ | 1 |
Agorastos, T; Bontis, JN; Goulis, DG; Pantazis, K; Vavilis, D; Zafrakas, M | 1 |
Faghihzadeh, S; Moghasemi, M; Ziaei, S | 1 |
Bai, WP; Chen, SL; Geng, L; Hu, LN; Liu, JL; Wang, SY; Zhang, ZL; Zheng, SR | 1 |
Kenemans, P | 1 |
Antsaklis, A; Dimitrakakis, C; Keramopoulos, D; Tsigginou, A | 1 |
Baber, R; Huang, KE | 1 |
Barrett, PH; Brown, SJ; Chan, DC; Hampton, RA; Stuckey, BG; Wagner, JM; Watts, GF | 1 |
Lumsden, MA; Sassarini, J | 1 |
Kloosterboer, HJ | 1 |
Biglia, N; Egberts, J; Kenemans, P; Kimmig, R; Kubista, E; Moggio, G; Mol-Arts, M; Mulder, R; Planellas, J; Sismondi, P | 1 |
Bao, W; Bouchard, P; Cheng, RJ; Constantine, G; de Villiers, TJ; Panay, N; Vincendon, P | 1 |
Almeida, M; Azevedo, G; Cavalcanti, MA; Martins, R; Morais-Socorro, M; Neto Francisco, P; Rezende, A | 1 |
Balduzzi, S; Basevi, V; Bassi, C; D'Amico, R; Formoso, G; Maestri, E; Magrini, N; Maltoni, S; Marata, AM; Perrone, E | 1 |
Eyster, KM; Hansen, KA | 1 |
Bennink, HJ; Engelen, S; Helmond, FA; Landgren, MB | 1 |
Metsä-Heikkilä, M; Ylikorkala, O | 1 |
Fogelman, I; Robinson, J; Rymer, J | 1 |
Di Carlo, C; Mastrantonio, P; Morelli, M; Nappi, C; Noia, R; Palomba, S; Russo, T; Zullo, F | 1 |
Morris, E; Rymer, J | 3 |
Bundred, N; Fentiman, IS; Foidart, JM; Helmond, FA; Kroiss, R; Kubista, E; Mol-Arts, M; Rymer, J | 1 |
Engelen, S; Helmond, FA; Landgren, MB | 1 |
Anderson, GL; Chlebowski, RT | 1 |
Chrystyn, H; Elfituri, A; Elmahaishi, M; Sherif, F | 1 |
Baber, R; Hickey, M; Kwik, M | 1 |
Busiello, A; Carbone, IF; D'Armiento, FP; De Falco, M; Di Lieto, A; Mascolo, M; Pollio, F; Salvatore, G; Staibano, S | 1 |
Antoine, C; Carly, B; Liebens, F; Pastijn, A; Rozenberg, S | 1 |
Gompel, A; Piette, JC | 1 |
Bai, W; Geng, L; Henneicke-von Zepelin, HH; Hu, L; Jiao, C; Liske, E; Liu, J; Wang, S; Zhang, Z; Zheng, S | 1 |
Diaby, V; Lachaine, J; Perreault, S | 1 |
Franke, HR; Hammar, ML; Nijland, EA; Pornel, B; van de Weijer, P; von Mauw, EM | 1 |
Lazovic, G; Marinkovic, J; Radivojevic, U | 1 |
Garefalakis, M; Hickey, M | 1 |
Christau, S; Garre, K; Hammar, M; Nathorst-Böös, J; Rud, T | 1 |
Akkad, A; Al-Azzawi, F; Habiba, M; Mason, T; Wahab, M | 1 |
Di Carlo, C; Di Spiezio Sardo, A; Guida, M; Nappi, C; Palomba, S; Tommaselli, GA | 1 |
Affinito, P; Di Carlo, C; Nappi, C; Palomba, S; Pellicano, M; Zullo, F | 1 |
Berendsen, HH; Kloosterboer, HJ; Weekers, AH | 1 |
Cummings, S; Modelska, K | 1 |
Malinova, M; Milchev, N; Pekhlivanov, B | 1 |
Duursma, SA; Meeuwsen, IB; Samson, MM; Verhaar, HJ | 1 |
Baracat, EC; Barbosa, IC; Giordano, MG; Haidar, MA; Marinho, RM; Menegocci, JC; Morais, KM; Tomaz, G; Wehba, S | 1 |
14 review(s) available for tibolone and Hot Flashes
Article | Year |
---|---|
Short-term and long-term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Randomized Controlled Trials as Topic; Stroke; Sweating; Uterine Hemorrhage | 2016 |
Updated clinical recommendations for the use of tibolone in Asian women.
Topics: Arthralgia; Breast Neoplasms; Cardiovascular Diseases; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Knowledge, Attitudes, Practice; Hot Flashes; Humans; Middle Aged; Musculoskeletal Diseases; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Rural Population; Sexual Dysfunctions, Psychological; Sleep Initiation and Maintenance Disorders; Urban Population | 2010 |
Hot flushes: are there effective alternatives to estrogen?
Topics: Acupuncture Therapy; Amines; Cimicifuga; Clonidine; Cyclohexanecarboxylic Acids; Estrogen Replacement Therapy; Exercise; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Menopause; New Zealand; Norpregnenes; Phytoestrogens; Progesterone; Selective Serotonin Reuptake Inhibitors; Skin; United Kingdom; United States; Vitamin E | 2010 |
Short and long term effects of tibolone in postmenopausal women.
Topics: Aged; Breast Neoplasms; Dyspareunia; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Postmenopause; Stroke; Sweating; Uterine Hemorrhage | 2012 |
Hormone replacement therapy in women with a history of breast cancer.
Topics: Breast Neoplasms; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Quality of Life; Risk Factors; Selective Estrogen Receptor Modulators | 2002 |
Menopausal symptoms.
Topics: Clonidine; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins | 2003 |
Menopausal symptoms.
Topics: Clonidine; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins | 2004 |
Menopausal symptoms.
Topics: Drug Therapy, Combination; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Phytoestrogens; Progestins | 2005 |
Therapy for menopausal symptoms during and after treatment for breast cancer : safety considerations.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Case-Control Studies; Clonidine; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Health Behavior; Hot Flashes; Humans; Menopause; Norpregnenes; Paroxetine; Personal Health Services; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Tamoxifen | 2005 |
Safety of alternative treatments for menopausal symptoms after breast cancer: a qualitative systematic review.
Topics: Antidepressive Agents; Breast Neoplasms; Estrogen Receptor Modulators; Female; Histamine H1 Antagonists; Hot Flashes; Humans; Menopause; Norpregnenes | 2007 |
Systemic lupus erythematosus and hormone replacement therapy.
Topics: Animals; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone; Progestins; Research Design; Risk Assessment; Thrombosis; Women's Health | 2007 |
Tibolone: the way to beat many a postmenopausal ailments.
Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrium; Estrogen Receptor Modulators; Estrogens; Female; Hot Flashes; Humans; Menopause; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Risk Factors; Stroke | 2008 |
Role of androgens, progestins and tibolone in the treatment of menopausal symptoms: a review of the clinical evidence.
Topics: Affect; Androgens; Cognition; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libido; Menopause; Middle Aged; Norpregnenes; Progestins; Testosterone | 2008 |
Tibolone for postmenopausal women: systematic review of randomized trials.
Topics: Adult; Affect; Aged; Aged, 80 and over; Double-Blind Method; Female; Hot Flashes; Humans; Lipids; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Randomized Controlled Trials as Topic; Sweating | 2002 |
22 trial(s) available for tibolone and Hot Flashes
Article | Year |
---|---|
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Osteoporosis, Postmenopausal; Vasomotor System | 2009 |
Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Topics: Cluster Analysis; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Libido; Middle Aged; Norpregnenes; Orgasm; Postmenopause; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Testosterone; Treatment Outcome | 2010 |
[Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Topics: Administration, Oral; Adult; Cimicifuga; Double-Blind Method; Endometrium; Female; Hot Flashes; Humans; Middle Aged; Nervous System Diseases; Norpregnenes; Perimenopause; Phytotherapy; Plant Extracts; Uterine Hemorrhage | 2009 |
What have we really learned from 'LIBERATE' trial?
Topics: Breast Neoplasms; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes | 2010 |
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy.
Topics: Aged; Apolipoprotein A-II; Cholesterol, HDL; Cross-Over Studies; Estrogen Receptor Modulators; Female; Fenofibrate; Hot Flashes; Humans; Hypolipidemic Agents; Lipoproteins, HDL; Middle Aged; Norpregnenes; Postmenopause | 2010 |
Effects of tibolone on climacteric symptoms and quality of life in breast cancer patients--data from LIBERATE trial.
Topics: Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Atrophic Vaginitis; Breast Neoplasms; Climacteric; Contraindications; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Intention to Treat Analysis; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Quality of Life; Surveys and Questionnaires; Tamoxifen | 2011 |
Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
Topics: Adult; Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Monitoring; Estrogen Receptor Modulators; Female; Follicle Stimulating Hormone; Hot Flashes; Humans; Menopause; Middle Aged; Neurotransmitter Uptake Inhibitors; Norpregnenes; Treatment Outcome; Vasomotor System | 2012 |
Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
Topics: Administration, Oral; Adult; Double-Blind Method; Endometrium; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Organ Size; Placebos; Treatment Outcome; Ultrasonography | 2012 |
Dose-response analysis of effects of tibolone on climacteric symptoms.
Topics: Adult; Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Sweating; Uterine Hemorrhage | 2002 |
Effect of tibolone on breast symptoms resulting from postmenopausal hormone replacement therapy.
Topics: Breast; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Incidence; Middle Aged; Norpregnenes; Pain; Pain Measurement; Postmenopause; Prospective Studies; Surveys and Questionnaires | 2003 |
The effect of tibolone in postmenopausal women receiving tamoxifen after surgery for breast cancer: a randomised, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Chemotherapy, Adjuvant; Double-Blind Method; Endometrium; Estrogen Antagonists; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Hyperhidrosis; Lipids; Mammography; Middle Aged; Neoplasm Recurrence, Local; Norpregnenes; Pilot Projects; Postmenopause; Tamoxifen | 2005 |
Tibolone relieves climacteric symptoms in highly symptomatic women with at least seven hot flushes and sweats per day.
Topics: Climacteric; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Europe; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Sweating; Treatment Outcome; Uterine Hemorrhage | 2005 |
Two hormone replacement therapy (HRT) regimens for middle-eastern postmenopausal women.
Topics: Administration, Oral; Adult; Dydrogesterone; Estradiol; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Libya; Longitudinal Studies; Middle Aged; Norpregnenes; Postmenopause; Prospective Studies; Severity of Illness Index; Treatment Outcome; White People | 2005 |
Preoperative treatment of uterine leiomyomas: clinical findings and expression of transforming growth factor-beta3 and connective tissue growth factor.
Topics: Adult; Antineoplastic Agents, Hormonal; Bone Density; Connective Tissue Growth Factor; Drug Therapy, Combination; Female; Hemoglobins; Hot Flashes; Humans; Immediate-Early Proteins; Immunohistochemistry; Injections, Subcutaneous; Intercellular Signaling Peptides and Proteins; Iron; Leiomyoma; Leuprolide; Myometrium; Neoadjuvant Therapy; Norpregnenes; Transforming Growth Factor beta; Transforming Growth Factor beta3; Uterine Neoplasms | 2006 |
Efficacy and tolerability of a medicinal product containing an isopropanolic black cohosh extract in Chinese women with menopausal symptoms: a randomized, double blind, parallel-controlled study versus tibolone.
Topics: Adult; Asian People; China; Cimicifuga; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Estrogen Receptor Modulators; Female; Hot Flashes; Humans; Menopause; Metrorrhagia; Middle Aged; Norpregnenes; Odds Ratio; Phytoestrogens; Phytotherapy; Plant Extracts; Statistics, Nonparametric | 2007 |
Tibolone and low-dose continuous combined hormone treatment: vaginal bleeding pattern, efficacy and tolerability.
Topics: Aged; Contraceptives, Oral, Synthetic; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Metrorrhagia; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes | 2007 |
A double-blind, randomised trial comparing the effects of tibolone and continuous combined hormone replacement therapy in postmenopausal women with menopausal symptoms.
Topics: Anabolic Agents; Double-Blind Method; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norethindrone; Norpregnenes; Postmenopause; Progesterone Congeners; Sexual Behavior; Sweating; Uterine Hemorrhage; Vaginal Diseases | 1998 |
Continuous combined hormone replacement therapy compared with tibolone.
Topics: Climacteric; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Lipoproteins; Menstruation; Middle Aged; Minor Histocompatibility Loci; Norethindrone; Norpregnenes; Progesterone Congeners | 1999 |
Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.
Topics: Adult; Anabolic Agents; Double-Blind Method; Drug Therapy, Combination; Female; Hot Flashes; Humans; Leuprolide; Norpregnenes; Placebos; Premenstrual Syndrome; Prospective Studies | 2001 |
Effectiveness of short-term administration of tibolone plus gonadotropin-releasing hormone analogue on the surgical outcome of laparoscopic myomectomy.
Topics: Adult; Combined Modality Therapy; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Iron; Laparoscopy; Leiomyoma; Leuprolide; Norpregnenes; Placebos; Prospective Studies; Treatment Outcome; Uterine Neoplasms | 2001 |
The influence of tibolone on quality of life in postmenopausal women.
Topics: Anabolic Agents; Double-Blind Method; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2002 |
A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
Topics: Aged; Animals; Coitus; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Female Urogenital Diseases; Horses; Hot Flashes; Humans; Lipids; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Uterine Hemorrhage; Weight Gain | 2002 |
12 other study(ies) available for tibolone and Hot Flashes
Article | Year |
---|---|
Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
Topics: Aged; Bone Density; Cardiovascular Diseases; Estrogen Replacement Therapy; Female; Hot Flashes; Humans; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Postmenopause; Quality of Life; Randomized Controlled Trials as Topic; Sexual Dysfunction, Physiological; Societies, Medical; Spain | 2013 |
Tibolone: the risk is too high.
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Clinical Trials as Topic; Estrogen Replacement Therapy; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Risk | 2009 |
Hormone therapy for postmenopausal breast cancer survivors: a survey among obstetrician-gynaecologists.
Topics: Breast Neoplasms; Data Collection; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Greece; Gynecology; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal; Practice Patterns, Physicians' | 2009 |
Tibolone revisited: still a good treatment option for healthy, early postmenopausal women.
Topics: Age Factors; Breast Neoplasms; Contraindications; Estrogen Receptor Modulators; Female; Heart Diseases; Hot Flashes; Humans; Norpregnenes; Patient Selection; Postmenopause; Risk Factors; Stroke | 2010 |
Historical milestones in the development of tibolone (Livial®).
Topics: Estrogen Receptor Modulators; Female; History, 20th Century; History, 21st Century; Hot Flashes; Humans; Norpregnenes; Osteoporosis, Postmenopausal | 2011 |
What happened to WHI: menopausal hormonal therapy in 2012.
Topics: Atrophy; Breast Neoplasms; Endometrial Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens; Female; Hot Flashes; Humans; Menopause; Middle Aged; Norpregnenes; Patient Selection; Raloxifene Hydrochloride; Vagina | 2012 |
Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.
Topics: Alkaline Phosphatase; Bone Density; Calcium; Case-Control Studies; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Female; Femur Neck; Hot Flashes; Humans; Lumbar Vertebrae; Middle Aged; Norpregnenes; Osteoporosis, Postmenopausal; Prospective Studies; Time Factors; United Kingdom; Vagina | 2002 |
Hot flashes. A closer look at causes and remedies.
Topics: Acetates; Amines; Antidepressive Agents; Body Temperature Regulation; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Female; Gabapentin; gamma-Aminobutyric Acid; Hot Flashes; Humans; Hypothalamus; Norpregnenes | 2003 |
Progestins and recurrence in breast cancer survivors.
Topics: Breast Neoplasms; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Europe; Female; Hot Flashes; Humans; Menopause; Neoplasm Recurrence, Local; Norpregnenes; Progestins; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Survivors; Treatment Outcome | 2005 |
Economic impact of Tibolone compared with Continuous-Combined Hormone Replacement Therapy in the management of climacteric symptoms in postmenopausal women.
Topics: Canada; Cost-Benefit Analysis; Drug Administration Schedule; Estrogen Receptor Modulators; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Hot Flashes; Humans; Markov Chains; Medroxyprogesterone Acetate; Middle Aged; Norpregnenes; Postmenopause; Quality-Adjusted Life Years | 2007 |
Effect of tibolone and raloxifene on the tail temperature of oestrogen-deficient rats.
Topics: Adrenergic alpha-Agonists; Anabolic Agents; Animals; Body Temperature; Clonidine; Dose-Response Relationship, Drug; Estradiol; Estrogens; Female; Hot Flashes; Humans; Motor Activity; Norpregnenes; Ovariectomy; Raloxifene Hydrochloride; Rats; Rats, Wistar; Selective Estrogen Receptor Modulators; Tail | 2001 |
[Our experience in the treatment of climacteric complaints with Livial (Organon)].
Topics: Anabolic Agents; Climacteric; Female; Hot Flashes; Humans; Nausea; Norpregnenes; Treatment Outcome; Uterine Hemorrhage | 2001 |